Why the study?
Do various treatment modalities improve freedom from symptomatic recurrence in patients with malignant pericardial effusion?
Population
Patients with malignant pericardial effusion
Design
Systematic_review
Authors
Loading...
Supports individualized procedural selection in malignant pericardial effusion; extends Level 1 evidence for durable, low-morbidity recurrence prevention.
Do various treatment modalities improve freedom from symptomatic recurrence in patients with malignant pericardial effusion?
Treatment of malignant pericardial effusions should be individualized based on patient condition and tumor type, utilizing modalities like pericardiocentesis, sclerotherapy, or pericardiotomy.
Paul T. Vaitkus (1994) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: